TABLE 5:

Baseline clinical and clinical outcome at 3 and 12 months

	Unruptured and Other	Recent SAH
At baseline	n = 87	n = 10
Baseline Rankin ≥2	81	—
Hunt & Hess grade
1 or 2	—	7
4		3
At discharge* with including re-treatment as applicable	n = 86†	n = 10
Rankin ≤2	76 (88%)	5
	(95% CI 79–94)
Rankin Unchanged/improved	75	—
Rankin Worsened	8 (9%)	—
Death at discharge	3	1
At 3–6 months including re-treatment as applicable	n = 82	n = 7
Rankin ≤2	74 (90%)	6
	(95% CI 82–96)
Rankin Unchanged/improved	74	7
Rankin Worsened	5	0
Death at discharge to 3 months	0	0
	1 lost to f/u
	1 no data at 3 mths
At 12-Months or latest f/u, with re-treatment as applicable	n = 83†	n = 7
Rankin ≤2	76 (91.5%)	4
	(95% CI 83–96)
Rankin Unchanged/improved	75	6
Rankin Worsened	3	0
Death at 3 months to 12 months	2	1

^*Discharge data missing in 1.

^†Includes four patients with no 3–6 month follow-up Rankin score.